Filing Details
- Accession Number:
- 0001140361-16-071335
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-07-01 06:02:04
- Reporting Period:
- 2016-06-30
- Filing Date:
- 2016-07-01
- Accepted Time:
- 2016-07-01 06:02:04
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1572552 | Asterias Biotherapeutics Inc. | AST | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1321073 | Lahue Stephen Cartt | 6300 Dumbarton Circle Fremont CA 94555 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2016-06-30 | 10,000 | $2.40 | 260,000 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $2.38 to $2.41, inclusive. The reporting person undertakes to provide to any stockholder of Asterias Biotherapeutics, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote to this Form 4.
Billionaire Hedge Funds
